Literature DB >> 10854207

Nuclear localization of catechol-O-methyltransferase in neoplastic and nonneoplastic mammary epithelial cells.

J Weisz1, G Fritz-Wolz, S Gestl, G A Clawson, C R Creveling, J G Liehr, D Dabbs.   

Abstract

Catechol-O-methyltransferase (COMT) plays both a regulatory and protective role in catechol homeostasis. It contributes to the regulation of tissue levels of catecholamines and catecholestrogens (CEs) and, by blocking oxidative metabolism of catechols, prevents endogenous and exogenous catechols from becoming a source of potentially mutagenic electrophiles. Evidence implicating CEs in carcinogenesis, in particular in the hamster kidney model of estrogen-induced cancer, has focused attention on the protective role of COMT in estrogen target tissues. We have previously reported that treating hamsters with estrogens causes translocation of COMT to nuclei of epithelial cells in the renal cortex, the site of CE biosynthesis and where the cancers arise. This finding suggested that nuclear COMT may be a marker of a threat to the genome by catechols, including CEs. It is postulated that CEs play a role in the genesis of breast cancer by contributing to a state of chronic oxidative stress that is presumed to underlie the high incidence of this disease in the United States. Therefore, here we used immunocytochemistry to re-examine human breast parenchyma for nuclear COMT. In addition to confirming previous reports of cytoplasmic COMT in mammary epithelial cells, we identified nuclear COMT in foci of mammary epithelial cells in histologically normal breast tissue of virtually all control (macromastia) and cancer patients and in breast cancer cells. There was no correlation between tissue histology and the numbers of cells with nuclear COMT, the size of foci containing such cells, or intensity of nuclear COMT immunostaining. The focal nature of the phenomenon suggests that nuclear COMT does not serve a housekeeping function but that it reflects a protective response to an increased local catechol load, presumably of CEs and, as such, that it may be a characteristic of the population of women studied who share the same major risk factor for developing breast cancer, that of living in the industrialized West.

Entities:  

Mesh:

Substances:

Year:  2000        PMID: 10854207      PMCID: PMC1850086          DOI: 10.1016/S0002-9440(10)65057-2

Source DB:  PubMed          Journal:  Am J Pathol        ISSN: 0002-9440            Impact factor:   4.307


  46 in total

Review 1.  Membrane-bound catechol-O-methyltransferase: a reevaluation of its role in the O-methylation of the catecholamine neurotransmitters.

Authors:  J A Roth
Journal:  Rev Physiol Biochem Pharmacol       Date:  1992       Impact factor: 5.545

Review 2.  Cancer risk and oxidative DNA damage in man.

Authors:  S Loft; H E Poulsen
Journal:  J Mol Med (Berl)       Date:  1996-06       Impact factor: 4.599

3.  The lifetime risk of developing breast cancer.

Authors:  E J Feuer; L M Wun; C C Boring; W D Flanders; M J Timmel; T Tong
Journal:  J Natl Cancer Inst       Date:  1993-06-02       Impact factor: 13.506

Review 4.  Breast cancer: magnitude of the problem and descriptive epidemiology.

Authors:  J L Kelsey; P L Horn-Ross
Journal:  Epidemiol Rev       Date:  1993       Impact factor: 6.222

5.  Gas chromatography/mass spectrometry of catechol estrogens.

Authors:  L A Castagnetta; O M Granata; F P Arcuri; L M Polito; F Rosati; G P Cartoni
Journal:  Steroids       Date:  1992-09       Impact factor: 2.668

Review 6.  Human breast cancer: concerted role of diet, prolactin and adrenal C19-delta 5-steroids in tumorigenesis.

Authors:  J B Adams
Journal:  Int J Cancer       Date:  1992-04-01       Impact factor: 7.396

7.  Genomic organization of the human catechol O-methyltransferase gene and its expression from two distinct promoters.

Authors:  J Tenhunen; M Salminen; K Lundström; T Kiviluoto; R Savolainen; I Ulmanen
Journal:  Eur J Biochem       Date:  1994-08-01

8.  The etiology and prediction of breast cancer. Fourier transform-infrared spectroscopy reveals progressive alterations in breast DNA leading to a cancer-like phenotype in a high proportion of normal women.

Authors:  D C Malins; N L Polissar; K Nishikida; E H Holmes; H S Gardner; S J Gunselman
Journal:  Cancer       Date:  1995-01-15       Impact factor: 6.860

9.  The effects of 2,3,7,8-tetrachlorodibenzo-p-dioxin on estrogen metabolism in MCF-7 breast cancer cells: evidence for induction of a novel 17 beta-estradiol 4-hydroxylase.

Authors:  D C Spink; C L Hayes; N R Young; M Christou; T R Sutter; C R Jefcoate; J F Gierthy
Journal:  J Steroid Biochem Mol Biol       Date:  1994-12       Impact factor: 4.292

Review 10.  DNA lesions, inducible DNA repair, and cell division: three key factors in mutagenesis and carcinogenesis.

Authors:  B N Ames; M K Shigenaga; L S Gold
Journal:  Environ Health Perspect       Date:  1993-12       Impact factor: 9.031

View more
  5 in total

Review 1.  Genes other than BRCA1 and BRCA2 involved in breast cancer susceptibility.

Authors:  M M de Jong; I M Nolte; G J te Meerman; W T A van der Graaf; J C Oosterwijk; J H Kleibeuker; M Schaapveld; E G E de Vries
Journal:  J Med Genet       Date:  2002-04       Impact factor: 6.318

2.  Expression of UGT2B7, a UDP-glucuronosyltransferase implicated in the metabolism of 4-hydroxyestrone and all-trans retinoic acid, in normal human breast parenchyma and in invasive and in situ breast cancers.

Authors:  Shelley A Gestl; Mitchell D Green; Debra A Shearer; Elizabeth Frauenhoffer; Thomas R Tephly; Judith Weisz
Journal:  Am J Pathol       Date:  2002-04       Impact factor: 4.307

3.  Surfactant protein A, an innate immune factor, is expressed in the vaginal mucosa and is present in vaginal lavage fluid.

Authors:  Colin MacNeill; Todd M Umstead; David S Phelps; Zhenwu Lin; Joanna Floros; Debra A Shearer; Judith Weisz
Journal:  Immunology       Date:  2004-01       Impact factor: 7.397

4.  Reduced COMT activity as a possible environmental risk factor for breast cancer. Opinion.

Authors:  C R Creveling
Journal:  Neurotox Res       Date:  2003       Impact factor: 3.911

5.  Catechol-O-methyltransferase: characteristics, polymorphisms and role in breast cancer.

Authors:  James D Yager
Journal:  Drug Discov Today Dis Mech       Date:  2012-06-01
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.